The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies.

<h4>Objective</h4>The axillary reverse mapping (ARM) technique has recently been developed to prevent lymphedema by preserving the arm lymphatic drainage during sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND) procedures. The objective of this systematic review...

Full description

Saved in:
Bibliographic Details
Main Authors: Chao Han, Ben Yang, Wen-Shu Zuo, Gang Zheng, Li Yang, Mei-Zhu Zheng
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0150285
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850110792329854976
author Chao Han
Ben Yang
Wen-Shu Zuo
Gang Zheng
Li Yang
Mei-Zhu Zheng
author_facet Chao Han
Ben Yang
Wen-Shu Zuo
Gang Zheng
Li Yang
Mei-Zhu Zheng
author_sort Chao Han
collection DOAJ
description <h4>Objective</h4>The axillary reverse mapping (ARM) technique has recently been developed to prevent lymphedema by preserving the arm lymphatic drainage during sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND) procedures. The objective of this systematic review and meta-analysis was to evaluate the feasibility and oncological safety of ARM.<h4>Methods</h4>We searched Medline, Embase, Web of science, Scopus, and the Cochrane Library for relevant prospective studies. The identification rate of ARM nodes, the crossover rate of SLN-ARM nodes, the proportion of metastatic ARM nodes, and the incidence of complications were pooled into meta-analyses by the random-effects model.<h4>Results</h4>A total of 24 prospective studies were included into meta-analyses, of which 11 studies reported ARM during SLNB, and 18 studies reported ARM during SLNB. The overall identification rate of ARM nodes was 38.2% (95% CI 32.9%-43.8%) during SLNB and 82.8% (78.0%-86.6%) during ALND, respectively. The crossover rate of SLN-ARM nodes was 19.6% (95% CI 14.4%-26.1%). The metastatic rate of ARM nodes was 16.9% (95% CI 14.2%-20.1%). The pooled incidence of lymphedema was 4.1% (95% CI 2.9-5.9%) for patients undergoing ARM procedure.<h4>Conclusions</h4>The ARM procedure was feasible during ALND. Nevertheless, it was restricted by low identification rate of ARM nodes during SLNB. ARM was beneficial for preventing lymphedema. However, this technique should be performed with caution given the possibility of crossover SLN-ARM nodes and metastatic ARM nodes. ARM appeared to be unsuitable for patients with clinically positive breast cancer due to oncological safety concern.
format Article
id doaj-art-165875ea51ef4e32a3061ffdc8553bb5
institution OA Journals
issn 1932-6203
language English
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-165875ea51ef4e32a3061ffdc8553bb52025-08-20T02:37:46ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01112e015028510.1371/journal.pone.0150285The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies.Chao HanBen YangWen-Shu ZuoGang ZhengLi YangMei-Zhu Zheng<h4>Objective</h4>The axillary reverse mapping (ARM) technique has recently been developed to prevent lymphedema by preserving the arm lymphatic drainage during sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND) procedures. The objective of this systematic review and meta-analysis was to evaluate the feasibility and oncological safety of ARM.<h4>Methods</h4>We searched Medline, Embase, Web of science, Scopus, and the Cochrane Library for relevant prospective studies. The identification rate of ARM nodes, the crossover rate of SLN-ARM nodes, the proportion of metastatic ARM nodes, and the incidence of complications were pooled into meta-analyses by the random-effects model.<h4>Results</h4>A total of 24 prospective studies were included into meta-analyses, of which 11 studies reported ARM during SLNB, and 18 studies reported ARM during SLNB. The overall identification rate of ARM nodes was 38.2% (95% CI 32.9%-43.8%) during SLNB and 82.8% (78.0%-86.6%) during ALND, respectively. The crossover rate of SLN-ARM nodes was 19.6% (95% CI 14.4%-26.1%). The metastatic rate of ARM nodes was 16.9% (95% CI 14.2%-20.1%). The pooled incidence of lymphedema was 4.1% (95% CI 2.9-5.9%) for patients undergoing ARM procedure.<h4>Conclusions</h4>The ARM procedure was feasible during ALND. Nevertheless, it was restricted by low identification rate of ARM nodes during SLNB. ARM was beneficial for preventing lymphedema. However, this technique should be performed with caution given the possibility of crossover SLN-ARM nodes and metastatic ARM nodes. ARM appeared to be unsuitable for patients with clinically positive breast cancer due to oncological safety concern.https://doi.org/10.1371/journal.pone.0150285
spellingShingle Chao Han
Ben Yang
Wen-Shu Zuo
Gang Zheng
Li Yang
Mei-Zhu Zheng
The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies.
PLoS ONE
title The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies.
title_full The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies.
title_fullStr The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies.
title_full_unstemmed The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies.
title_short The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies.
title_sort feasibility and oncological safety of axillary reverse mapping in patients with breast cancer a systematic review and meta analysis of prospective studies
url https://doi.org/10.1371/journal.pone.0150285
work_keys_str_mv AT chaohan thefeasibilityandoncologicalsafetyofaxillaryreversemappinginpatientswithbreastcancerasystematicreviewandmetaanalysisofprospectivestudies
AT benyang thefeasibilityandoncologicalsafetyofaxillaryreversemappinginpatientswithbreastcancerasystematicreviewandmetaanalysisofprospectivestudies
AT wenshuzuo thefeasibilityandoncologicalsafetyofaxillaryreversemappinginpatientswithbreastcancerasystematicreviewandmetaanalysisofprospectivestudies
AT gangzheng thefeasibilityandoncologicalsafetyofaxillaryreversemappinginpatientswithbreastcancerasystematicreviewandmetaanalysisofprospectivestudies
AT liyang thefeasibilityandoncologicalsafetyofaxillaryreversemappinginpatientswithbreastcancerasystematicreviewandmetaanalysisofprospectivestudies
AT meizhuzheng thefeasibilityandoncologicalsafetyofaxillaryreversemappinginpatientswithbreastcancerasystematicreviewandmetaanalysisofprospectivestudies
AT chaohan feasibilityandoncologicalsafetyofaxillaryreversemappinginpatientswithbreastcancerasystematicreviewandmetaanalysisofprospectivestudies
AT benyang feasibilityandoncologicalsafetyofaxillaryreversemappinginpatientswithbreastcancerasystematicreviewandmetaanalysisofprospectivestudies
AT wenshuzuo feasibilityandoncologicalsafetyofaxillaryreversemappinginpatientswithbreastcancerasystematicreviewandmetaanalysisofprospectivestudies
AT gangzheng feasibilityandoncologicalsafetyofaxillaryreversemappinginpatientswithbreastcancerasystematicreviewandmetaanalysisofprospectivestudies
AT liyang feasibilityandoncologicalsafetyofaxillaryreversemappinginpatientswithbreastcancerasystematicreviewandmetaanalysisofprospectivestudies
AT meizhuzheng feasibilityandoncologicalsafetyofaxillaryreversemappinginpatientswithbreastcancerasystematicreviewandmetaanalysisofprospectivestudies